Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9085555 Complement pathway modulators and uses thereof

Patent 9085555 was granted and assigned to Novartis on July, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

90855550

Date of Patent

July 21, 2015

Patent Application Number

133421610

Date Filed

January 2, 2012

Patent Citations Received

‌

US Patent 11926617 Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

‌

US Patent 12083114 Inhibitors of SARM1 in combination with neuro-protective agents

‌

US Patent 12076319 Therapeutic regimens for treatment of paroxysmal nocturnal hemoglobinuria

‌

US Patent 11708351 Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

‌

US Patent 12006307 Pharmaceutical compounds for treatment of medical disorders

Patent Primary Examiner

‌

David K O Dell

Patent abstract

The present invention provides a compound of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9085555 Complement pathway modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API